| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |